Sun Anthony Y's Form 4/A amendment
AmendedZentalis Pharmaceuticals, Inc. (ZNTL) · filed Dec 7, 2021
- Accession no.
- 0001725160-21-000236
- Filed
- Dec 7, 2021
- Trade date
- Nov 26, 2021
- Filing delay
- 11 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Dec 2, 2021
This filing lists 1 non-derivative transaction. It carries over 16 transactions from the original filing that it did not restate. Open-market sales total $1.62M. It was filed 11 days after the trade.
This amendment restates part of 0001725160-21-000232 (filed Dec 2, 2021). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sun Anthony YCIK 0001377952 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2021 | Common Stock | GGiftDisposed | −125,000 | $0.00 | $0 | 103,650 | Indirect |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001725160-21-000232 (filed Dec 2, 2021).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 26, 2021 | Common Stock | GGiftAcquired | +125,000 | $0.00 | $0 | 125,000 | Indirect | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −1,548 | $73.36F3 | −$113,561.28 | 1,123,053 | Direct | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −921 | $74.23F4 | −$68,365.83 | 1,122,132 | Direct | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −800 | $75.85F5 | −$60,680 | 1,121,332 | Direct | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −500 | $77.09F6 | −$38,545 | 1,120,832 | Direct | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −396 | $78.59F7 | −$31,121.64 | 1,120,436 | Direct | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −3,502 | $79.65F8 | −$278,934.3 | 1,116,934 | Direct | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −2,700 | $80.32F9 | −$216,864 | 1,114,234 | Direct | |
| Dec 1, 2021 | Common Stock | SSaleDisposed | −104 | $81.12 | −$8,436.48 | 1,114,130 | Direct | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −311 | $72.76F10 | −$22,628.36 | 1,113,819 | Direct | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −1,289 | $73.62F11 | −$94,896.18 | 1,112,530 | Direct | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −600 | $74.68F12 | −$44,808 | 1,111,930 | Direct | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −500 | $75.99F13 | −$37,995 | 1,111,430 | Direct | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −3,824 | $77.36F14 | −$295,824.64 | 1,107,606 | Direct | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −3,823 | $77.97F15 | −$298,079.31 | 1,103,783 | Direct | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −124 | $78.85F16 | −$9,777.4 | 1,103,659 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F3
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $72.91 to $73.90. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $73.91 to $74.67. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $75.34 to $76.20. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $76.81 to $77.42. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F7
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.07 to $79.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F8
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $79.10 to $80.08. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F9
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $80.11 to $80.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F10
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $72.12 to $73.00. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F11
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $73.23 to $74.05. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F12
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $74.45 to $75.29. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F13
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $75.62 to $76.53. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F14
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $76.72 to $77.70. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F15
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $77.74 to $78.40. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F16
The price reported is a weighted average price. The shares were sold in multiple transactions at per share prices ranging from $78.77 to $79.18. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Reporting Person's original Form 4 filed on December 2, 2021 contained an error in the form of ownership of the Common Stock gifted to the Hao Jiao Zi Trust LLC by the Reporting Person's spouse on November 26, 2021, and mistakenly indicated that these shares were gifted by the Reporting Person directly. This Form 4/A corrects the error and presents the correct number of shares of common stock beneficially owned by the Reporting Person's spouse and by the Reporting Person directly following the reported transaction.